Clinical Impact of IPACK Block Addition to Suprainguinal Fascia Iliaca Block

Analgesia Clinical Trial

Official title:

Clinical Impact of IPACK Block Addition to Suprainguinal Fascia Iliaca Block in Knee Arthroplasty Patients Under Spinal Anesthesia: A Retrospective Cohort Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06054945
• Other study ID #: SIFIB+IPACK
• Status: Completed
• Start date: September 3, 2023
• Est. completion date: September 15, 2023

Study information

• Verified date: September 2023
• Source: Samsun University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

In our clinic, routine suprainguinal fascia iliaca block (SIFIB) has been administered for postoperative analgesia in patients undergoing knee arthroplasty. Recently, we have introduced the IPACK (Infiltration between the Popliteal Artery and Capsule of the Knee) block to this regimen, and the aim of this retrospective study is to determine whether the addition of the IPACK block enhances the quality of analgesia.

Knee arthroplasty, also known as knee joint replacement surgery, is a common procedure performed to alleviate pain and improve joint function in patients with knee osteoarthritis or other knee-related conditions. Postoperative pain management is crucial for patient comfort and overall recovery.

In this study, we aimed to compare the two techniques mentioned earlier, namely the SIFIB (Suprainguinal Fascia Iliaca Block) and the SIFIB+IPACK, by examining the data of patients who underwent knee arthroplasty under spinal anesthesia at our clinic between January 1, 2023, and September 1, 2023.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 88
• Est. completion date: September 15, 2023
• Est. primary completion date: September 15, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• Patients meeting the following criteria and whose postoperative follow-up forms were completed in full were included in the study

• Patients underwent total knee arthroplasty (TKA)

• ASA class I to III.

• operated under spinal anesthesia

• patient controlled analjgesia device was used for analgesia

Exclusion Criteria:

Patients whose data were inaccessible or had incomplete follow-up forms were excluded from the study to ensure the accuracy and reliability of our analysis.

• PCA device problems in follow up in 24 hours

• anesthesia plans were converted to general anesthesia

• spinal anesthesia failure

• peripheral blocks used other than protocol

Related Conditions & MeSH terms

• Acute Pain
• Analgesia
• Pain Management

Intervention

Procedure:
• SIFIB (suprainguinal fascia iliaca block)
Ultrasound guided Suprainguinal Fascia Iliaca Block for Knee Arthroplasty Patients

Other:
• IPACK (Interspace between the popliteal artery and capsule of the posterior knee )
Ultrasound guided IPACK (Interspace between the popliteal artery and capsule of the posterior knee ) Block for Knee Arthroplasty Patients

Device:
• Patient controlled anagesia device
Those who were administered opioids with PCA as rescue analgesic in the postoperative analgesia plan on the selected dates will be included in the study.

Locations

Country	Name	City	State
Turkey	Samsun University	Samsun

Sponsors (1)

Lead Sponsor	Collaborator
Samsun University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Opioid consumption	Opioid consumption via PCA device	24 hours
Secondary	NRS scores	NRS scores in different time frames. In a Numerical Rating Scale (NRS), patients are asked to circle the number between 0 and 10, that fits best to their pain intensity. Zero usually represents 'no pain at all' whereas the upper limit represents 'the worst pain ever possible'.	24 hours